Trial
NCT03325894
Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Attention Deficit Hyperactivity Disorder (ADHD)
Intervention
SHP465
Why stopped
The study was stopped due to efficacy reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-03